Fulcrum Therapeutics (FULC) Amortizatization of Intangibles (2020 - 2026)

Fulcrum Therapeutics' (FULC) quarterly Amortizatization of Intangibles came in at $767000.0 in Q1 2026, down 14.68% year-on-year from $899000.0 in Q1 2025, and up 100.26% on a QoQ basis from $383000.0 in Q4 2025.

Fulcrum Therapeutics (FULC) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Fulcrum Therapeutics (FULC) has 7 years of Amortizatization of Intangibles data on file, last reported at $767000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 14.68% year-over-year to $767000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a 31.69% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 32.76% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $767000.0, up from $383000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for FULC reached as high as $1.7 million in Q2 2023 and fell as low as -$353000.0 in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $820647.1 across 5 years, with a median of $945000.0 in 2024.
  • Across the five-year window, Amortizatization of Intangibles sank 377.03% in 2022 and surged 1515.18% in 2023, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $601000.0 in 2022, then soared by 120.97% to $1.3 million in 2023, then decreased by 28.84% to $945000.0 in 2024, then tumbled by 59.47% to $383000.0 in 2025, then jumped by 100.26% to $767000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $767000.0 in Q1 2026, $383000.0 in Q4 2025, and $586000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Fulcrum Therapeutics 285.43 Mn 285.43 Mn - 767,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 767,000.00
Mar 31, 2026 767,000.00
Dec 31, 2025 383,000.00
Dec 31, 2025 383,000.00
Sep 30, 2025 586,000.00
Sep 30, 2025 586,000.00
Jun 30, 2025 1.09 Mn
Jun 30, 2025 1.09 Mn
Mar 31, 2025 899,000.00
Mar 31, 2025 899,000.00
Dec 31, 2024 945,000.00
Dec 31, 2024 945,000.00
Sep 30, 2024 1.15 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 1.13 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.16 Mn
Mar 31, 2024 1.16 Mn
Dec 31, 2023 1.33 Mn
Dec 31, 2023 1.33 Mn